GlassScriptPhysician profile
Melissa Lea Ingram
NPI 1346690781
$518.34
in general payments reported to CMS, 2019-2025
8 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Psychiatric/Mental Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $244).
See the full distribution for Psychiatric/Mental Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.57 · 2022: $49.44 · 2023: $170 · 2024: $96.84 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.37 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $88.72 | 2022-2025 | Uzedy, Austedo |
| Lundbeck LLC | $86.74 | 2021-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.68 | 2022-2025 | Caplyta |
| Corium, LLC | $56.00 | 2023-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $53.54 | 2023 | Jornay Pm |
| Neurocrine Biosciences, INC. | $32.24 | 2023-2025 | Ingrezza |
| Idorsia Pharmaceuticals US INC | $16.05 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.